Study of the Effect of Chondroitin Sulfate(CONDROSAN) on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI

Trial Profile

Study of the Effect of Chondroitin Sulfate(CONDROSAN) on Structural Changes in Knee Osteoarthritis Patients Assessed by MRI

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Jun 2017

At a glance

  • Drugs Chondroitin sulfate (Primary) ; Celecoxib
  • Indications Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Acronyms MOSAIC
  • Sponsors Bioiberica
  • Most Recent Events

    • 14 Jun 2017 According to a Bioiberica media release, results from this and the CONCEPT trial will be presented at the 2017 Annual European Congress of Rheumatology.
    • 09 Jan 2017 Primary endpoint (Cartilage Volume Loss of the Lateral Compartment) has been met, according to a Bioiberica media release.
    • 09 Jan 2017 According to a Bioiberica media release, results from the study were published in the Arthritis Research and Therapy journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top